Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)
Journal Article
Hickman, M., Dillon, J. F., Elliott, L., De Angelis, D., Vickerman, P., Foster, G., …Hutchinson, S. J. (2019)
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol). BMJ Open, 9(9), https://doi.org/10.1136/bmjopen-2019-029538
Hepatitis C virus (HCV) is the second largest contributor to liver disease in the UK, with injecting drug use as the main risk factor among the estimated 200 000 people curren...
Hepatitis C in a new therapeutic era: Recontextualising the lived experience
Journal Article
Whiteley, D., Whittaker, A., Elliott, L., & Cunningham-Burley, S. (2017)
Hepatitis C in a new therapeutic era: Recontextualising the lived experience. Journal of Clinical Nursing, https://doi.org/10.1111/jocn.14083
Aims and Objectives
To explore the experience of adults living with hepatitis C in a new era of interferon-free treatment.
Background
Hepatitis C is a leading cause of morbidi...